1,096 results on '"Soliman, Osama"'
Search Results
52. TCT-474 ACURATE neo2 Implantation Without Balloon Predilatation (Direct ACURATE neo2)
53. Carvacrol-Loaded Phytosomes for Enhanced Wound Healing: Molecular Docking, Formulation, DoE-Aided Optimization, and in vitro/in vivo Evaluation
54. Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)
55. Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS)
56. Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document
57. Tricuspid valve disease and cardiac implantable electronic devices.
58. Multimodal Imaging of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer—A State-of-the-Art Review
59. Neocommissural/Coronary Alignment With a Novel Balloon Expandable Transcatheter Aortic Valve
60. Association between three-year mortality after transcatheter aortic valve implantation and paravalvular regurgitation graded by videodensitometry in comparison with visual grading
61. Commissural/Coronary Alignment With the Novel Myval Octacor THV - The Octa Align Technique
62. The Early neo2 Registry: Transcatheter Aortic Valve Implantation With ACURATE neo2 in a European Population
63. Quantitative aortography for assessment of aortic regurgitation in the era of percutaneous aortic valve replacement
64. Future Perspectives
65. E-14 | Left ventricular systolic recovery and reverse cardiac remodeling in patients with aortic stenosis after TAVI: A systematic review and meta-analysis
66. A Novel Angiographic Quantification of Aortic Regurgitation After TAVR Provides an Accurate Estimation of Regurgitation Fraction Derived From Cardiac Magnetic Resonance Imaging
67. Importance of Contrast Aortography With Lotus Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the RESPOND Post-Market Study
68. Correction to: Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients
69. Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials
70. Advances in transcatheter mitral and tricuspid therapies
71. Is the Cardiovascular Specialist Ready For the Fifth Revolution? The Role of Artificial Intelligence, Machine Learning, Big Data Analysis, Intelligent Swarming, and Knowledge-Centered Service on the Future of Global Cardiovascular Healthcare Delivery.
72. Management of acute aortic syndrome with evolving individualized precision medicine solutions: Lessons learned over two decades and literature review
73. One-Year Outcomes after Myval Implantation in Patients with Bicuspid Aortic Valve Stenosis—A Multicentre Real-World Experience
74. Efficacy of Levosimendan Infusion in Patients Undergoing Left Ventricular Assist Device Implantation in a propensity score-matched analysis of the EUROMACS Registry – the Euro LEVO-LVAD Study
75. CORE LAB QUANTIFICATION OF POST-TAVR AORTIC REGURGITATION IN PATIENTS TREATED WITH JENAVALVE FOR SEVERE PURE NATIVE AORTIC REGURGITATION
76. Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer
77. CRT-700.47 Commissural/Coronary Alignment With the Novel Myval Octacor THV - The Octa Align Technique
78. Valve Replacement for Pure Native Aortic Regurgitation From Alpha to Omega
79. Machine Learning Approaches for Segmentation of Cardiovascular Neurocristopathy Related Images
80. Balloon Rupture during Pre-Dilation for Transcatheter Aortic Valve Replacement in Patients with a Bicuspid Aortic Valve: Classification, Treatment Strategies, and Prevention
81. Quantification of Contrast Kinetics in Clinical Imaging
82. Predictors of Conduction Disturbances Requiring New Permanent Pacemaker Implantation following Transcatheter Aortic Valve Implantation Using the Evolut Series.
83. Long-Term Benefit of Myectomy and Anterior Mitral Leaflet Extension in Obstructive Hypertrophic Cardiomyopathy
84. Case report: Transcatheter aortic valve replacement in a large bicuspid anatomy using the XL-Myval 32 mm
85. Core Lab Adjudication of the ACURATE neo2 Hemodynamic Performance Using Computed-Tomography-Corrected Left Ventricular Outflow Tract Area
86. Quantitative videodensitometric assessment of residual mitral regurgitation after transcatheter mitral valve replacement: a first-in-human report from China
87. Improvement of the Ocular Bioavailability of Econazole Nitrate upon Complexation with Cyclodextrins
88. Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate
89. Nimodipine Ophthalmic Formulations for Management of Glaucoma
90. A granular approach to improve reproducibility of the echocardiographic assessment of paravalvular regurgitation after TAVI
91. One-year results of minimally invasive fusion surgery of the sacroiliac joint as an alternative treatment after failed endoscopic thermal coagulation
92. TCT-504 Quantitative Angiographic Assessment of Post-TAVR Residual Aortic Regurgitation in Patients Treated With Portico vs Navitor Transcatheter Heart Valve: Independent Core Lab Analysis
93. TCT-503 Objective Quantification of Post-TAVR Aortic Regurgitation in the Real World Using 12 Different Types of Transcatheter Heart Valves: A Multicenter Pooled Analysis
94. TCT-429 Core Lab Quantification of Post-TAVR Aortic Regurgitation in Patients Treated With JenaValve for Severe Pure Native Aortic Regurgitation
95. TEVAR and EVAR, the unknown knowns of the cardiovascular hemodynamics; and the immediate and long-term consequences of fabric material on major adverse clinical outcome
96. Two decades of experience in explantation and graft preserving strategies following primary endovascular aneurysm repair and lessons learned
97. Management of retroperitoneal fibrosis with endovascular aneurysm repair in patients refractory to medical management
98. Response by Soliman et al to Letter Regarding Article, “Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients With Mechanical Circulatory Support) Right-Sided Heart Failure Risk Score”
99. Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients with Mechanical Circulatory Support) Right-Sided Heart Failure Risk Score
100. Comparison of valve performance of the mechanically expanding Lotus and the balloon-expanded SAPIEN3 transcatheter heart valves: an observational study with independent core laboratory analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.